Lexicon Pharmaceuticals, Inc. (LXRX) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Lexicon Pharmaceuticals, Inc. (LXRX) closed at USD 1.60 on 2026-10-14, a change of +16.8 % over the past year, with a market capitalization of USD 734.18M.

Lexicon Pharmaceuticals, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Lexicon Pharmaceuticals, Inc. key figures

Previous close

USD 1.60 (2026-10-14)

1-year change

+16.8 %

Market cap

USD 734.18M

Enterprise value

USD 602.81M

P/E ratio (trailing)

-10.31

P/E ratio (forward)

-8.66

EPS (trailing)

-0.16

EPS (forward)

-0.19

PEG ratio

-13.77

Price to book

4.21

Revenue growth

-97.6 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

7.60

Employees

81

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. The company develops sotagliflozin, an orally-delivered small molecule drug for the treatment of hypertrophic cardiomyopathy, and ZYNQUISTA (sotagliflozin) for the treatment of type 1 diabetes. It also commercializes INPEFA (sotagliflozin), a once-daily oral tablet to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure or type 2 diabetes, CKD, and other cardiovascular risk factors. In addition, the company develops LX9851, an orally-delivered small molecule drug candidate for the treatment of obesity and associated cardiometabolic disorders, and pilavapadin (LX9211), an orally-delivered small molecule drug candidate for the treatment of neuropathic pain. It has strategic collaboration and license agreements with Viatris Inc. and Bristol-Myers Squibb Company. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Lexicon Pharmaceuticals, Inc. and compare it with other stocks.